The company's gene-editing-focused platform looks promising.
A new narrative review argues that human brain organoids are reshaping stroke research by exposing human-specific injury ...
Whales that rarely get cancer. Sharks that live for centuries. Salamanders that regrow limbs. Discover the hidden biology ...
A 2026 review finds that bacteriophages can selectively alter gut bacteria, but durable human microbiome reconstruction remains unproven.
Vertex Pharmaceuticals (NASDAQ:VRTX) outlined updates across its kidney disease pipeline at the American Society of Nephrology Kidney Week 2026, highlighting data for povetacicept in IgA nephropathy ...
Thalassemia is an inherited blood disorder that prevents the body from producing enough healthy haemoglobin to carry oxygen ...
Exelixis will have to wait longer than expected to earn approval for a new drug. It's not the end of the world.
crisp_bioでは、2026年6月17日に、「プライムエディター (PE) のLNP製剤による生体内遺伝子治療の実現可能性が高まっています」と題する記事を配信しました。Nature Biotechnology誌から刊行されたハーバード大学・ブロード研究所のDavid R. Liu教授が責任著者である研究論文 ...
Cientistas usam prime editing no corpo humano pela primeira vez para tentar corrigir mutação genética que causa doença de ...
Интересные новости науки за неделю ДНК человека впервые отредактировали прямо внутри организма Биотехнологическая компания Prime Medicine ...
Bilim insanları, birincil düzenleme (prime editing) tekniğini kullanarak insan DNA'sını ilk kez doğrudan vücut içinde değiştirdi. Wilson hastalığının tedavisinde çığır açabilecek bu yöntem, karmaşık l ...
过去几年,从 AlphaFold 到生成式分子设计,AI 几乎成了制药行业最热的技术叙事之一。 近日,知名学者 Daphne Koller 在 a16z News 发表长文《Drug Discovery Has No Magic Wands》,把问题重新拉回到药物研发最原始的一步:在让 AI 设计药物之前,人类有多了解疾病机制? Daphne Koller 是机器学习领域的代表性学者之一,曾在斯坦 ...